title: Initial and long-term outcome of 83 patients after balloon angioplasty of totally occluded bypass grafts.
abstract: OBJECTIVE
  This study was designed to evaluate the safety and short- and long-term results of coronary angioplasty of totally occluded bypass grafts in patients with clinical conditions other than acute myocardial infarction.
  
  
  BACKGROUND
  Total occlusion of bypass grafts after coronary artery surgery often causes recurrent ischemia. The safety and results of percutaneous transluminal coronary angioplasty in occluded bypass grafts are controversial.
  
  
  METHODS
  All patients with dilation of a totally occluded bypass graft attempted between 1981 and 1991 were retrospectively identified from a data base. Patients treated in the setting of an acute myocardial infarction were excluded. Eighty-three patients met these criteria and constitute the study group. Hospital records, office charts and procedural reports were reviewed in all patients to supplement details available in the data base.
  
  
  RESULTS
  The time from bypass surgery to attempted coronary angioplasty ranged from 1 to 226 months (mean time 88 months). The mean (+/- SD) duration of graft occlusion was 31 +/- 46 days (range 1 to 180). In 27 attempts the bypass graft was the only site dilated, and in 56 attempts (68%) one to six other sites (n = 101) were dilated. Angiographic success (< or = 40% residual lumen stenosis) was achieved in 61 grafts (73%) and 98 of the additional sites (97%) (p < 0.001). Major complications included one procedural death and two Q wave infarctions. Follow-up for a mean of 32 months demonstrated a 1- and 3-year actuarial survival rate of 94% and 80%, respectively. At 3 years, only 34% of patients were free of repeat angioplasty or surgery.
  
  
  CONCLUSIONS
  Angioplasty of totally occluded bypass grafts can be successful in the majority of selected patients, although major complications can occur. Strategies for sustained patency are needed to improve the long-term results.
authors.affiliation: Mid America Heart Institute, St. Luke's Hospital, Kansas City, Missouri.
authors.forename: J K
authors.initials: JK
authors.lastname: Kahn
authors.forename: B D
authors.initials: BD
authors.lastname: Rutherford
authors.forename: D R
authors.initials: DR
authors.lastname: McConahay
authors.forename: W L
authors.initials: WL
authors.lastname: Johnson
authors.forename: L V
authors.initials: LV
authors.lastname: Giorgi
authors.forename: T M
authors.initials: TM
authors.lastname: Shimshak
authors.forename: R W
authors.initials: RW
authors.lastname: Ligon
authors.forename: G O
authors.initials: GO
authors.lastname: Hartzler
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000787:Angina Pectoris / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D016896:Treatment Outcome